Moderna chief executive officer talks Q1 earnings, Brazil COVID vaccine, and cancer treatment markets



Shares of pharmaceutical enterprise Moderna (MRNA) are on the rise despite first quarter losses.
Moderna chief executive officer Stéphane Bancel tells Yahoo money management Senior Reporter Anjalee Khemlani that the enterprise is busy developing updated coronavirus vaccines for the 2024-2025 season and recently announced an expansion into the Brazilian industry. As the coronavirus pandemic has shifted toward an endemic, Bancel explains how Moderna continues to innovate, sharing a positive outlook on phase two data for a combination flu and coronavirus vaccine.
#youtube #equities #yahoofinance

About Yahoo money management:

Yahoo money management provides free stock ticker data, up-to-date news, investment mix management resources, comprehensive industry data, advanced tools, and more information to help you manage your financial life.

– Get the latest news and data at money management.yahoo.com

– Download the Yahoo money management app on Apple (https://apple.co/3Rten0R) or Android (https://bit.ly/3t8UnXO)

– Follow Yahoo money management on social:

X: http://twitter.com/YahooFinance
Instagram: https://www.instagram.com/yahoofinance/?hl=en
TikTok: https://www.tiktok.com/@yahoofinance?lang=en
Facebook: https://www.facebook.com/yahoofinance/
LinkedIn: https://www.linkedin.com/enterprise/yahoo-money management


Disclaimer:

If you own the YouTube channel related to this video and do not want it to be featured here, you can contact us through our contact page. We will gladly remove it without questioning your reasons.

Leave a Comment